Dabigatran Renal Dose Adjustment — CrCl Threshold

Assess dabigatran dosing and contraindication thresholds based on CrCl for atrial fibrillation stroke prevention and VTE treatment, noting 80% renal elimination requiring dose reduction and avoidance in severe CKD.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assess dabigatran dosing and contraindication thresholds based on CrCl for atrial fibrillation stroke prevention and VTE treatment, noting 80% renal elimination requiring dose reduction and avoidance in severe CKD

Each component has a specific meaning:

  • CrCl — The crcl recorded for the scenario being assessed.

Note: Interpret the dabigatran renal dose result against the thresholds and context described above.

How to Use

Enter the CrCl for the scenario you are assessing. Assess dabigatran dosing and contraindication thresholds based on CrCl for atrial fibrillation stroke prevention and VTE treatment, noting 80% renal elimination requiring dose reduction and avoidance in severe CKD. Use the dabigatran renal dose result to inform your calculation.

Frequently Asked Questions